UA94465C2 - Combination preparations comprising bifeprunox and l-dopa - Google Patents

Combination preparations comprising bifeprunox and l-dopa

Info

Publication number
UA94465C2
UA94465C2 UAA200900252A UAA200900252A UA94465C2 UA 94465 C2 UA94465 C2 UA 94465C2 UA A200900252 A UAA200900252 A UA A200900252A UA A200900252 A UAA200900252 A UA A200900252A UA 94465 C2 UA94465 C2 UA 94465C2
Authority
UA
Ukraine
Prior art keywords
dopa
bifeprunox
combination preparations
bifeprnnox
simultaneous
Prior art date
Application number
UAA200900252A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Эндрю К. Маккрири
Шарренбург Густаф Й.М. ван
Мартинус Т.М. Тульп
Original Assignee
Сольве Фармасьютикалз Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сольве Фармасьютикалз Б.В. filed Critical Сольве Фармасьютикалз Б.В.
Publication of UA94465C2 publication Critical patent/UA94465C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Abstract

The invention concerns the use of a combination preparation of bifeprnnox or its N-oxide, or pharmacologically acceptable salts of those compounds: and L-DOPA, for simultaneous, separate or sequential use in the treatment of disorders requiring recovery of dopaminergic function, in particular Parkinson's disease and restless leg syndrome.
UAA200900252A 2006-06-16 2007-06-15 Combination preparations comprising bifeprunox and l-dopa UA94465C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06115587 2006-06-16

Publications (1)

Publication Number Publication Date
UA94465C2 true UA94465C2 (en) 2011-05-10

Family

ID=37156018

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200900252A UA94465C2 (en) 2006-06-16 2007-06-15 Combination preparations comprising bifeprunox and l-dopa

Country Status (7)

Country Link
CN (1) CN101478990A (en)
AR (1) AR061357A1 (en)
BR (1) BRPI0713691A2 (en)
MX (1) MX2008016226A (en)
SA (1) SA07280316B1 (en)
TW (1) TW200815031A (en)
UA (1) UA94465C2 (en)

Also Published As

Publication number Publication date
SA07280316B1 (en) 2010-10-19
BRPI0713691A2 (en) 2012-10-30
MX2008016226A (en) 2009-01-19
AR061357A1 (en) 2008-08-20
TW200815031A (en) 2008-04-01
CN101478990A (en) 2009-07-08

Similar Documents

Publication Publication Date Title
TW200635582A (en) Medicaments for the treatment or prevention of fibrotic diseases
LU93321I2 (en) IBRUTINIB, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
UA92584C2 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
MX2009002196A (en) Buprenophine-wafer for drug substitution therapy.
WO2006095029A3 (en) Di-polymer protein conjugates and processes for their preparation
WO2005097135A3 (en) Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives
HK1100765A1 (en) Use of rotigotine for treating and preventing parkinson's plus syndrome
UA102517C2 (en) Substituted morpholine and thiomorpholine derivatives, pharmaceutical composition based thereon and use thereof for the preparation of medicament for the treatment of a disorder or disease of the central nervous system
IL190150A0 (en) New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease
BR0312573A (en) Phenyl- [4- (3-phenyl-1h-pyrazol-4-yl) -pyrimidin-2-yl] -amine derivatives
MY146429A (en) 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e-]-[1,2,4]-triazolo-[1,5-c-]-pyrimidin-5-amine
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
MX2009004561A (en) Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain.
ES2267706T3 (en) AGENTS AS NICOTINAMIDE OR CARDR FOR THE TREATMENT OF SKIN DISORDERS.
MX2010006204A (en) 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases.
MX2009011869A (en) Liquorice extract antimicrobial and anti-inflammatory isolates.
WO2007144422A3 (en) Combination preparations comprising bifeprunox and l-dopa
TW200612922A (en) Inhibitors of hsp90
WO2009068708A3 (en) Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
ES2325291A1 (en) Use of a silybum marianum extract
MY148457A (en) Combination preparations comprising slv308 and a dopamine agonist
UA94465C2 (en) Combination preparations comprising bifeprunox and l-dopa
UA94461C2 (en) Aqueous tobacco leaf extract, uses thereof in the treatment of dependence